Nate is a seasoned leader with more than 17 years of experience spanning a variety of roles with a particular focus on the biopharmaceutical and pharma services sectors. At Ora, he is responsible for the strategy, planning and execution of the enterprise’s finance and accounting operations.
Before joining Ora, he was the Chief Financial Officer for BioAgilytix, a leading bioanalytical laboratory CRO supporting the drug development efforts of biotech and pharmaceutical customers globally.
Prior to BioAgilytix, Nate served as Chief Commercial Officer for PPD’s laboratory services business (now part of Thermo Fisher Scientific) and held several other roles including Senior Vice President of Finance, where he led the company’s FP&A, Treasury, Capital Markets, and Investor Relations functions. Nate and his team were heavily involved in the company’s 2020 initial public offering. Before PPD, Nate was the Treasurer for Acelity, a medical device company now part of 3M and earlier in his career served as a Vice President at Morgan Stanley, where he focused on raising capital for clients in the healthcare and biopharmaceutical sectors.
